MDGL
Madrigal Pharmaceuticals
$533.12
−$13.56 (−2.48%)Sep 10, 2026
Key metrics
The numbers that frame MDGL today
- Market cap
- $12.32B
- P/E (TTM)
- -37.9
- EV / FCF
- -59.1
- Gross margin
- 91.5%
- EV / Sales
- 9.6
- ROIC
- -29.3%
- Div yield
- 0%
- Debt / equity
- 0.7
- 52wk Low
- $393.61
- 52wk High
- $615.00
Growth
Revenue and earnings trend for MDGL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MDGL
Is Madrigal Pharmaceuticals a good buy?
Hold. Madrigal Pharmaceuticals has strong momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Madrigal Pharmaceuticals is selling at a high price.
What is the market capitalization of MDGL?
Madrigal Pharmaceuticals's market capitalization is $12.32B.
What is the P/E ratio for MDGL stock?
Madrigal Pharmaceuticals's current P/E ratio is -37.9.
What is the 52-week high for MDGL stock?
The 52-week high for Madrigal Pharmaceuticals is $615.00. The current close of $533.12 is 13.3% below that high.
What is the 52-week low for MDGL stock?
The 52-week low for Madrigal Pharmaceuticals is $393.61. The current close of $533.12 is 35.4% above that low.
Does MDGL stock pay dividends?
Madrigal Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MDGL?
Madrigal Pharmaceuticals's Debt / Equity ratio is 0.66.